A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors

BACKGROUND: Patients with Ewing sarcoma family of tumors (ESFT) who are resistant even to salvage chemotherapy, have dismal prognoses and few therapeutic options. Because the docetaxel/irinotecan (DI) combination has not been previously evaluated in ESFT, we prospectively evaluated its use in patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yoon, Jong Hyung, Kwon, Mi Mi, Park, Hyeon Jin, Park, Seog Yun, Lim, Kun Young, Joo, Jungnam, Park, Byung-Kiu
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4155244/
https://ncbi.nlm.nih.gov/pubmed/25164234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-622
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars